Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma

Korfel, Agnieszka; Schlegel, Uwe; Herrlinger, Ulrich; Dreyling, Martin; Schmidt, Christian; von Baumgarten, Luisa; Pezzutto, Antonio; Grobosch, Thomas; Kebir, Sied; Thiel, Eckhard; Martus, Peter; Kiewe, Philipp

dc.contributor.author	Martus, Peter
dc.date.accessioned	2017-01-04T10:30:24Z
dc.date.available	2017-01-04T10:30:24Z
dc.date.issued	2016
dc.identifier.issn	1527-7755
dc.identifier.uri	http://hdl.handle.net/10900/73879
dc.language.iso	en	de_DE
dc.publisher	Amer Soc Clinical Oncology	de_DE
dc.relation.uri	http://dx.doi.org/10.1200/JCO.2015.64.9897
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20160915142648_00730
utue.publikation.seiten	1757-	de_DE
utue.personen.roh	Korfel, Agnieszka
utue.personen.roh	Schlegel, Uwe
utue.personen.roh	Herrlinger, Ulrich
utue.personen.roh	Dreyling, Martin
utue.personen.roh	Schmidt, Christian
utue.personen.roh	von Baumgarten, Luisa
utue.personen.roh	Pezzutto, Antonio
utue.personen.roh	Grobosch, Thomas
utue.personen.roh	Kebir, Sied
utue.personen.roh	Thiel, Eckhard
utue.personen.roh	Martus, Peter
utue.personen.roh	Kiewe, Philipp
dcterms.isPartOf.ZSTitelID	Journal of Clinical Oncology	de_DE
dcterms.isPartOf.ZS-Issue	15	de_DE
dcterms.isPartOf.ZS-Volume	34	de_DE
utue.fakultaet	Universität Tübingen (ohne Fakultätsangabe)